Le Lézard
Classified in: Health, Science and technology
Subject: Conference

Longhorn Vaccines & Diagnostics Announces Poster Presentation at IDWeek 2019

Longhorn Vaccines & Diagnostics an innovative molecular tool, assay and vaccine development company focused on serving unmet critical needs in both developed and developing nations, will present scientific data at IDWeek 2019, which will be held in Washington, D.C. on October 2-6.

Updated pre-clinical data will be presented on Longhorn Vaccines & Diagnostics' leading candidates for a universal influenza vaccine. The patented configuration combines multiple conserved regions on the influenza virus. Data will be presented demonstrating strong activity against influenza strains across both group 1 and 2. This approach builds on vaccine candidates that have recently entered the clinical stage that cross strains within groups but not across group. Clara Sei, Director of Microbiology & Immunology Laboratory Longhorn Vaccines & Diagnostics, will present the poster. Further details will be available on the date of presentation.

Presentation Details:

Title: Peptide Vaccines Utilizing Conserved Hemagglutinin, Neuraminidase, and Matrix Ectodomain Influenza Epitopes Demonstrate Functional Activity Against Group 1 and 2 Influenza Strains

Location: Walter E. Washington Convention Center, Exhibit Hall BC

Date: Saturday, October 5

Time: 12:15 pm ET ? 1:30 pm ET

About Longhorn Vaccines and Diagnostics

Longhorn Vaccines & Diagnostics is an innovative molecular tool, assay and vaccine development company focused on serving unmet critical needs in both developed and developing nations. Longhorn's core product, PrimeStore® Molecular Transport Medium (MTM), is a patented, FDA approved, state-of-the-art ambient temperature molecular diagnostic collection and transport device that can help governments, global health organizations and drug manufacturers improve the diagnosis and treatment of infectious diseases such as mycobacterium tuberculosis (TB) and Influenza. Unlike standard devices for collecting and transporting TB samples, MTM is the first molecular transport device that can safely deactivate pathogens and stabilize RNA and DNA, allowing enhanced point of care and ambient temperature transport for laboratory based molecular testing and characterization. Longhorn is based in Bethesda, Maryland.

These press releases may also interest you

at 13:10
Insight Enterprises , the global integrator of Insight Intelligent Technology Solutionstm for organizations of all sizes, was named as Microsoft's 2020 Worldwide Customer Experience Partner of the Year on Monday for its ability to understand today's...

at 13:05
Technavio has been monitoring the video streaming software market and it is poised to grow by USD 6.38 billion during 2020-2024, progressing at a CAGR of over 19% during the forecast period. The report offers an up-to-date analysis regarding the...

at 13:05
?  Highlights:  New Barracuda CloudGen WAN is the first secure global SD-WAN service built natively on Microsoft Azure. The new...

at 13:03
StackHawk, the software-as-a-service startup that empowers software engineers to easily find and fix application security bugs, today announced that Simon Bennetts has joined the team as Distinguished Engineer, Assessment Technologies. Bennetts will...

at 13:01
The world has a problem with plastic waste and despite global plastic production continuing to accelerate, recycling rates remain stubbornly low., with only about 15% of the 400 million tonnes of plastic currently produced annually being recycled,...

at 13:00
Multi-platinum singer, songwriter and activist, Halsey, today shared a very special YouTube live performance (available for 24 hours) featuring some of her biggest chart-topping hits to mark her campaign collaboration with Magnum ice cream, which...

News published on 19 september 2019 at 10:05 and distributed by: